Emerging molecular markers of cancer

A genetic model for colorectal tumorigenesis

Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634

Serial Analysis of Gene Expression

Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995) · Science · doi:10.1126/science.270.5235.484 · Cited by 3,713

Use of proteomic patterns in serum to identify ovarian cancer

Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236

Telomerase Catalytic Subunit Homologs from Fission Yeast and Human

Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256

A gene hypermethylation profile of human cancer.

Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992

Hepatogastroenterology

Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977

Untitled work

(1977) · PubMed · Cited by 1,801

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,615

Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.

Schena, M., Shalon, D., Heller, R. A., Chai, A., Brown, P. O., & Davis, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10614 · Cited by 1,599

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Pollack, J. R., Perou, C. M., Alizadeh, A. A., Eisen, M. B., Pergamenschikov, A., Williams, C. F., Jeffrey, S. S., Botstein, D., & Brown, P. O. (1999) · Nature Genetics · doi:10.1038/12640 · Cited by 1,416

Aberrant methylation of p16 INK4a is an early event in lung cancer and a potential biomarker for early diagnosis

Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E. W., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 957

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921

Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples

Sidransky, D., von Eschenbach, A., Tsai, Y., Jones, P. A., Summerhayes, I. C., Marshall, F. F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875

Somatic mutations of the mitochondrial genome in human colorectal tumours

Polyák, K., Li, Y., Zhu, H., Christoph Lengauer, C., Willson, J. K. V., Markowitz, S. D., Trush, M. A., Kinzler, K. W., & Vogelstein, B. (1998) · Nature Genetics · doi:10.1038/3108 · Cited by 834

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829

Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids

Fliss, M., Usadel, H., Caballero, O. L., Wu, L. J., Buta, M. R., Eleff, S. M., Jen, J., & Sidransky, D. (2000) · Science · doi:10.1126/science.287.5460.2017 · Cited by 821

Predicting lung cancer by detecting aberrant promoter methylation in sputum.

Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (2000) · PubMed · Cited by 816

Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck

Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., & Sidransky, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502163320704 · Cited by 749

Cochrane review on screening for breast cancer with mammography

Olsen, O., & Gøtzsche, P. C. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06449-2 · Cited by 714

Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors

Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1566048 · Cited by 696

Microsatellite alterations in serum DNA of head and neck cancer patients

Nawroz, H., Koch, W. M., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 656

Microsatellite alterations in plasma DNA of small cell lung cancer patients

Chen, X. Q., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647

Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction

Smith, B., Selby, P. J., Southgate, J., Pittman, K. B., Bradley, C., & Blair, G. E. (1991) · The Lancet · doi:10.1016/0140-6736(91)92100-g · Cited by 631

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

Pietras, R. J., Arboleda, J., Dm, R., Wongvipat, N., Pegram, M. D., Ramos, L., Cm, G., Mg, P., Sliwkowski, M. X., & Dj, S. (1995) · PubMed · Cited by 603

Micrometastases and Survival in Stage II Colorectal Cancer

Liefers, G., Cleton-Jansen, A., van de Velde, C. J. �., Hermans, J., van Krieken, J. H. J. M., Cornelisse, C. J., & Tollenaar, R. A. �. �. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390403 · Cited by 586

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Argani, P., Iacobuzio–Donahue, C. A., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E. M., Yeo, C. J., et al. (2001) · PubMed · Cited by 574

Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540

Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel

Ahlquist, D. A., Skoletsky, J., Boynton, K. A., Harrington, J. J., Mahoney, D. W., Pierceall, W. E., Thibodeau, S. N., & Shuber, A. P. (2000) · Gastroenterology · doi:10.1053/gast.2000.19580 · Cited by 526

Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity

Wright, W. E., Shay, J. W., & Piatyszek, M. A. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3794 · Cited by 474

Microsatellite alterations as clonal markers for the detection of human cancer.

Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F. B., & Sidransky, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9871 · Cited by 447

Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

Datta, Y. H., Adams, P., Drobyski, W. R., Ethier, S. P., Terry, V. H., & Roth, M. S. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.475 · Cited by 417

Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

Rosas, S. L. B., Koch, W. M., Carvalho, M. D. G., Wu, L., Califano, J. A., Westra, W. H., Jen, J., & Sidransky, D. (2001) · PubMed · Cited by 409

Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.

Lo, Y. M. D., Chan, L. Y. S., Chan, A. T. �., Leung, S. F., Lo, K. W., Zhang, J., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 390

Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays

Hacia, J. G., Fan, J., Ryder, O. A., Li, J., Edgemon, K., Ghandour, G., Mayer, R. A., Sun, B. K., Hsie, L., Robbins, C. M., et al. (1999) · Nature Genetics · doi:10.1038/9674 · Cited by 380

Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border

Yancopoulos, G. D., Klagsbrun, M., & Folkman, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81426-9 · Cited by 379

Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis

Mao, L., Schoenberg, M., Scicchitano, M. S., Erozan, Y. S., Merlo, A. U., Schwab, D., & Sidransky, D. (1996) · Science · doi:10.1126/science.271.5249.659 · Cited by 377

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

Kawakami, K. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1805 · Cited by 373

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.

Gerhard, M., Juhl, H., Kalthoff, H., Schreiber, H. W., Wagener, C., & Neumaier, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.725 · Cited by 369

Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.

Lo, Y. M. D., Chan, A. T. �., Chan, L. Y. S., Leung, S. F., Lam, C., Huang, D. P., & Johnson, P. J. (2000) · PubMed · Cited by 341

Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer

Ahrendt, S. A., Chow, J. T., Xu, L., Yang, S., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L. J., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 341

Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets

Dong, S. M., Traverso, G., Johnson, C., Geng, L., Favis, R., Boynton, K. A., Hibi, K., Goodman, S. N., D’Allessio, M., Paty, P. B., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.858 · Cited by 334

Detection ofAPCMutations in Fecal DNA from Patients with Colorectal Tumors

Traverso, G., Shuber, A. P., Levin, B., Johnson, C., Olsson, L., Schoetz, D. J., Hamilton, S. R., Boynton, K. A., Kinzler, K. W., & Vogelstein, B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012294 · Cited by 325

Serum p53 antibodies as early markers of lung cancer

Lubin, R., Zalcman, G., Bouchet, L., Trédaniel, J., Legros, Y., Cazals-Hatem, D. L., Hirsch, A., & Soussi, T. (1995) · Nature Medicine · doi:10.1038/nm0795-701 · Cited by 317

Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma

Jerónimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., & Sidransky, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1747 · Cited by 308

Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

Naour, F. L., Misek, D. E., Krause, M. C., Deneux, L., Giordano, T. J., Scholl, S., & Hanash, S. (2001) · PubMed · Cited by 306

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302

Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.

Zippelius, A., Kufer, P., Honold, G., Köllermann, M. W., Oberneder, R., Schlimok, G., Riethmüller, G., & Pantel, K. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2701 · Cited by 274

Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer

Bostwick, D. G., Alexander, E. E., Singh, R., Shan, A., Qian, J., Santella, R. M., Oberley, L. W., Yan, T., Zhong, W., Jiang, X., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1 · Cited by 273

Detection of bladder cancer recurrence by microsatellite analysis of urine

Steiner, G., Schoenberg, M., Linn, J. F., Mao, L., & Sidransky, D. (1997) · Nature Medicine · doi:10.1038/nm0697-621 · Cited by 270

Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma

Inoue, K., Ozeki, Y., Suganuma, T., Sugiura, Y., & Tanaka, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970115)79:2 · Cited by 254

Proteomics in Early Detection of Cancer

Srinivas, P. R., Srivastava, S., Hanash, S., & Wright, G. L. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1901 · Cited by 252

Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.

Sánchez‐Céspedes, M., Parrella, P., Nomoto, S., Cohen, D., Xiao, Y. Q., Esteller, M., Jerónimo, C., Jordan, R. C. K., Nicol, T. L., Koch, W. M., et al. (2001) · PubMed · Cited by 236

Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array

Ahrendt, S. A., Halachmi, S., Chow, J. T., Li, W., Halachmi, N., Yang, S. C., Wehage, S. L., Jen, J., & Sidransky, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7382 · Cited by 228

Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer

Grady, W. M., Raiput, A., Lutterbaugh, J., & Markowitz, S. D. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)81443-8 · Cited by 224

Isoelectric Focusing Nonporous RP HPLC: A Two-Dimensional Liquid-Phase Separation Method for Mapping of Cellular Proteins with Identification Using MALDI-TOF Mass Spectrometry

Wall, D. B., Kachman, M. T., Gong, S., Hinderer, R., Parus, S., Misek, D. E., Hanash, S., & Lubman, D. M. (2000) · Analytical Chemistry · doi:10.1021/ac991332t · Cited by 211

Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.

Brichory, F., Beer, D., Naour, F. L., Giordano, T. J., & Hanash, S. (2001) · PubMed · Cited by 203

Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.

Capone, R. B., Pai, S. I., Koch, W. M., Gillison, M. L., Nawroz-Danish, H., Westra, W. H., Daniel, R. W., Shah, K. V., & Sidransky, D. (2000) · PubMed · Cited by 188

Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.

Krismann, M., Todt, B., Schröder, J., Gareis, D., Müller, K., Seeber, S., & Schütte, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.11.2769 · Cited by 186

Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.

Spafford, M. F., Koch, W. M., Reed, A. L., Califano, J. A., Xu, L., Eisenberger, C. F., Yip, L., Leong, P. L., Wu, L., Liu, S. X., et al. (2001) · PubMed · Cited by 170

The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction

Foss, A. J. E., Guille, M., Occleston, N. L., Hykin, P. G., Hungerford, J. L., & Lightman, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.293 · Cited by 165

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16INK4A, p21WAF-1, cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

Kawesha, A., Ghaneh, P., Andrén‐Sandberg, Å., Ögraed, D., Skar, R., Dawiskiba, S., Evans, J. D., Campbell, F., Lemoine, N. R., & Neoptolemos, J. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6 · Cited by 152

Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.

Taback, B., Chan, A. D., Kuo, C. T., Bostick, P. J., Wang, H.-J., Giuliano, A. E., & Hoon, D. S. �. (2001) · PubMed · Cited by 147

Cancer proteomics: from biomarker discovery to signal pathway profiling.

Bichsel, V. E., Liotta, L. A., & Petricoin, E. (2001) · PubMed · Cited by 127

A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood.

Brossart, P., Schmier, J. W., Krüger, S., Willhauck, M., Scheibenbogen, C., Möhler, T., & Keilholz, U. (1995) · PubMed · Cited by 123

Protein based microarrays: A tool for probing the proteome of cancer cells and tissues

Madoz‐Gúrpide, J., Wang, H., Misek, D. E., Brichory, F., & Hanash, S. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10 · Cited by 122

New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics

Paweletz, C. P., Liotta, L. A., & Petricoin, E. F. (2001) · Urology · doi:10.1016/s0090-4295(00)00964-x · Cited by 120

Detection of K-ras Oncogene Mutations in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis

Mills, N. E., Fishman, C. L., Scholes, J. V., Anderson, S. E., Rom, W. N., & Jacobson, D. R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.14.1056 · Cited by 120

Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients.

Califano, J. A., Ahrendt, S. A., Meininger, G. R., Westra, W. H., Koch, W. M., & Sidransky, D. (1996) · PubMed · Cited by 109

Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.

Hayashi, N., Arakawa, H., Nagase, H., Yanagisawa, A., Kato, Y., Ohta, H., Takano, S., Ogawa, M., & Nakamura, Y. (1994) · PubMed · Cited by 106

Proteomic Approaches within the NCI Early Detection Research Network for the Discovery and Identification of Cancer Biomarkers

Verma, M., Wright, G. L., Hanash, S., Gopal-Srivastava, R., & Srivastava, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03870.x · Cited by 106

Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.

Jackson, P. E., Qian, G., Friesen, M. D., Zhu, Y. R., Lu, P., Wang, J. B., Wu, Y., Kensler, T. W., Vogelstein, B., & Groopman, J. D. (2001) · PubMed · Cited by 105

Detection of K-ras Mutation in Colonic Effluent Samples From Patients Without Evidence of Colorectal Carcinoma

Tohi, M., Luo, F., & Ronai, Z. A. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.13.1007 · Cited by 102

Comparison of Methods of Measuring HER-2 in Metastatic Breast Cancer Patients Treated With High-Dose Chemotherapy

Harris, L. N., Liotcheva, V. B., Broadwater, G., Ramirez, M. J., Maimonis, P. J., Anderson, S., Everett, T., Harpole, D. H., Moore, M. B., Berry, D. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1698 · Cited by 96

Fine-needle aspiration of the adult kidney

Renshaw, A. A., Granter, S. R., & Cibas, E. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970425)81:2 · Cited by 96

Circulating nucleic acids in plasma or serum

Anker, P., Lyautey, J., Lederrey, C., & Stroun, M. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00666-0 · Cited by 95

Entering the Postgenome Era

Nowak, R. (1995) · Science · doi:10.1126/science.270.5235.368 · Cited by 90

Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications

Yoshida, K., Sugino, T., Steve Goodison, B., Warren, B., Nolan, D. J., Wadsworth, S. J., Mortensen, N., Toge, T., Tahara, E., & Tarin, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.96 · Cited by 80

Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.

Chu, E., Drake, J. C., Koeller, D. M., Zinn, S., Jamis‐Dow, C., Yeh, G. C., & Allegra, C. J. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10875-4 · Cited by 67

NCCN Practice Guidelines for Colorectal Cancer.

Benson, A. B., Choti, M. A., Cohen, A. M., Doroshow, J. H., Fuchs, C., Kiel, K. D., Martin, E., McGinn, C. J., Petrelli, N. J., Posey, J. A., et al. (2000) · PubMed · Cited by 58

Detection of tumor mutations in the presence of excess amounts of normal DNA

Sun, X., Hung, K., Wu, L. J., Sidransky, D., & Guo, B. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-186 · Cited by 53

Loss of Heterozygosity Assay for Molecular Detection of Cancer Using Energy-transfer Primers and Capillary Array ElectrophoresisPreprint

Medintz, I. L., Lee, C. R., Wong, W. W., Pirkola, K., Sidransky, D., & Mathies, R. A. (2000) · Genome Research · doi:10.1101/gr.10.8.1211 · Cited by 53

Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis.

izares, F. C. N., Sola, J. J., rez, M. P. E., Tovar, I., Heras, M. D. L., Salinas, J., afiel, R. P. N., & Nez, P. (2001) · Tumor Biology · doi:10.1159/000050627 · Cited by 50

Über Wachstum von Krebszellen in Medien, deren Glucose durch Galaktose ersetzt ist

Warburg, O. H., Geissler, A. W., & Lorenz, S. (1967) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1967.348.1.1686 · Cited by 46

Computational gene discovery and human disease

Rawlings, C., & Searls, D. B. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80158-x · Cited by 34

Differences in Sensitivity of Biological Functions Mediated by Epidermal Growth Factor Receptor Activation with Respect to Endogenous and Exogenous Ligands

Sawhney, R. S., Zhou, G.-H. K., Humphrey, L. E., Ghosh, P., Kreisberg, J. I., & Brattain, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103268200 · Cited by 34

[On growth of cancer cells in media in which glucose is replaced by galactose].

Warburg, O. H., Geissler, A. W., & Lorenz, S. (1967) · PubMed · Cited by 32

Serum tumour markers CA 15-3, TPA, TPS, hCG β and TATI in the monitoring of chemotherapy response in metastatic breast cancer

Sjöström, J., Alfthan, H. V., Joensuu, H., Stenman, U., Lundin, J. E., & BLOMQVIST, C. P. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510152567068 · Cited by 30

Prospective controlled survey of viral infections in children with acute lymphoblastic leukemia during chemotherapy

Möttönen, M. I., Uhari, M. K., Lanning, M., & Tuokko, H. (1995) · Cancer · doi:10.1002/1097-0142(19950401)75:7 · Cited by 27

Tests for carcinoembryonic antigen. Role in diagnosis and management of cancer

Gold, P. (1975) · JAMA · doi:10.1001/jama.234.2.190 · Cited by 23

2-D or not 2-D--is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting.

Hanash, S. (2001) · PubMed · Cited by 21

Advances in the treatment of non-small cell lung cancer: Molecular markers take the stage

Rosell, R. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90301-x · Cited by 20

Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer

Urgell, E., Puig, P., Boadas, J., Capellá, G., Queraltó, J. M., Boluda, R., Antonijuan-Parés, A., Farré, A., Lluı́s, F., González‐Sastre, F., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00288-4 · Cited by 18

Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance

Jassem, E., Bigda, J., Dziadziuszko, R., Schlichtholz, B., Roux, D. L., Grodzki, T., Rzyman, W., Konopa, K., Pobereżna, M., Dobrzańska, Z., et al. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00150-1 · Cited by 15

Tests for Carcinoembryonic Antigen

Gold, P. (1975) · JAMA · doi:10.1001/jama.1975.03260150060026 · Cited by 15

Adriamycin and cytoxan in the treatment of inoperable lung cancer

Hoeltgen, T., Macintyre, J. M., Perlia, C. P., Lagakos, S. W., Stolbach, L. L., & Bennett, J. M. (1983) · Cancer · doi:10.1002/1097-0142(19830601)51:11 · Cited by 13

Diagnosis of localized prostate cancer: 10 years of progress

Feneley, M. R., & Partin, A. W. (2000) · Current Opinion in Urology · doi:10.1097/00042307-200007000-00006 · Cited by 13

Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer.

Ohara, K., Tatsuzaki, H., Molotkova, N. G., Oda, T., Yuzawa, K., Saida, Y., Matsuzaki, Y., Shimizu, W., Todoroki, T., Fukao, K., et al. (2001) · PubMed · Cited by 13

The fundamental role of epigenetic events in cancer

Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648

Cancer genes and the pathways they control

Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,346

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502

Multiplexed electrical detection of cancer markers with nanowire sensor arrays

Zheng, G., Patolsky, F., Cui, Y., Wang, W. U., & Lieber, C. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1138 · Cited by 2,461

Cancer molecular markers: A guide to cancer detection and management

Nair, M., Sandhu, S. S., & Sharma, A. K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.002 · Cited by 85

Nucleic acid based molecular markers in the diagnosis of cancer

Kumari, A., & Kumar, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00048-6

Cancer Diagnosis with Molecular Markers

Sahoo, S. (2020) · doi:10.37421/mbl.2020.09.255

Molecular markers for cancer prognosis and treatment: Have we struck gold?

Nowsheen, S., Aziz, K., Panayiotidis, M. I., & Georgakilas, A. G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.022 · Cited by 41

Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer

Sell, S., & Garrett, C. T. (1995) · Humana Press eBooks · doi:10.1007/978-1-4757-2381-6_1